Mosquito Coils: Why Is Strategies Dermal Toxicity Testing Important for Product Safety?

Mosquito coils remain a widely used mosquito-control product. Their operation is relatively simple: one end of the coil is ignited and allowed to smolder slowly, releasing active ingredients into the surrounding environment.

Despite this simple mode of use, mosquito coils are formulations that may contain insecticidal active ingredients, binders, fillers, fragrances, and other components. Safety evaluation should therefore consider not only efficacy against mosquitoes but also potential human exposure to the product and its components.

Inhalation exposure is an important consideration because mosquito coils are used through combustion. However, skin contact may also occur when the product is handled, moved, or accidentally comes into contact with the skin.

So, why can dermal toxicity testing be an important part of product safety evaluation?

Table of Content:

• Mosquito Coils Contain Insecticidal Active Ingredients
• Dermal Exposure Can Occur During Product Handling
• Hazard and Exposure Risk Are Different
• What Is Dermal Toxicity Testing?
• Why Is Dermal Toxicity Testing Important?
• The Final Formulation Matters
• From Efficacy to Measurable Safety

Mosquito Coils Contain Insecticidal Active Ingredients

Many mosquito coils products use compounds from the pyrethroid group as active ingredients. These insecticides primarily act by affecting voltage-gated sodium channels in the insect nervous system.

The active ingredient is formulated with various other components to provide the desired product structure, stability, burning characteristics, and release profile. Safety evaluation therefore needs to consider not only the identity of the active ingredient but also its concentration, final formulation, product characteristics, and potential routes of exposure.

Read Also:
5 Facts About Mosquito Coils: From How They Work to Strategies Efficacy Testing

Dermal Exposure Can Occur During Product Handling

Mosquito coils are designed to release their active ingredients while smoldering. However, before use, they may come into contact with the hands when removed from packaging, separated, placed on a holder, or moved.

Unintentional contact with product materials may also occur during manufacturing, packaging, distribution, or consumer use. The extent of dermal exposure can depend on factors such as the amount of material contacting the skin, concentration, contact area, duration of exposure, skin condition, and physicochemical characteristics of the substance.

The dermal route may therefore be considered as part of a safety assessment when it is relevant to product characteristics and exposure scenarios.

Hazard and Exposure Risk Are Different

The presence of a chemical substance in a formulation does not automatically mean that the product will cause adverse effects under every condition of use. Safety assessment requires an important distinction between hazard and risk.

Hazard refers to the intrinsic ability of a substance to cause an adverse effect. Risk considers the likelihood that the effect will occur under a particular level and pattern of exposure.

Therefore, evaluating safety requires more than reviewing an ingredient list. Manufacturers should also consider how exposure may occur, through which routes, for how long, and at what level.

Toxicological data can provide a scientific basis for this evaluation.

What Is Dermal Toxicity Testing?

Dermal toxicity testing is used to evaluate toxic effects associated with exposure to a substance or product through the skin under a defined study design. Dermal studies can have different objectives depending on the method used.

Therefore, dermal toxicity testing should not automatically be considered equivalent to skin irritation testing. Skin irritation testing specifically evaluates the potential for local effects, such as inflammatory responses or reversible skin damage, under defined exposure conditions.

Toxicity studies using the dermal route may have a broader purpose and can evaluate effects following skin exposure at defined doses and durations. The appropriate method should therefore be selected according to the assessment objective, formulation characteristics, potential exposure, and applicable requirements.

Why Is Dermal Toxicity Testing Important?

During mosquito coils development, toxicological data can contribute to establishing the product's overall safety profile. When skin exposure represents a relevant route, dermal toxicity testing can provide data to help evaluate potential effects associated with exposure through the skin.

Such data may contribute to:

• formulation safety evaluation;
• potential hazard identification;
• exposure-based risk assessment;
• formulation development or optimization;
• determination of relevant precautionary measures; and
• supporting applicable regulatory data requirements.

However, mosquito coil safety should not be concluded from a single test alone. Because these products are used through combustion, safety evaluation may require a risk-based approach that considers multiple relevant exposure routes.

The Final Formulation Matters

Safety information on an active ingredient provides an important starting point, but the final formulation may have characteristics that differ from those of the individual ingredient. Interactions among active ingredients, carriers, binders, fragrances, combustible materials, and other formulation components can influence product characteristics.

Concentration and dosage form can also affect how exposure occurs. Manufacturers should therefore evaluate the product as a whole. The question should not only be “Is this active ingredient safe?” but also “What is the safety profile of the final formulation under relevant exposure scenarios?”

From Efficacy to Measurable Safety

Mosquito-control products are expected not only to work against their target organisms but also to be developed with user safety in mind. Efficacy testing can provide information about product performance against mosquitoes, while toxicological evaluation provides different information concerning product safety.

Therefore, efficacy and safety are two distinct aspects that should be evaluated according to the product's characteristics and intended use. Laboratory testing helps manufacturers move from formulation-based assumptions toward more objective and measurable product evaluation.

Test Your Product's Safety

Don't just demonstrate that your mosquito-control product works—support its safety evaluation with laboratory testing data! IML Testing & Research provides Toxicity Testing services to help companies obtain data for evaluating product safety using relevant parameters and testing approaches.

Developing mosquito coils or other pest-control products? Contact IML Testing & Research today and discuss your Toxicity Testing requirements with our team!

Author & Editor: Lina

References

Liu, W., Zhang, J., Hashim, J. H., Jalaludin, J., Hashim, Z., & Goldstein, B. D. (2003). Mosquito coil emissions and health implications. Environmental Health Perspectives, 111(12), 1454–1460.

Soderlund, D. M. (2012). Molecular mechanisms of pyrethroid insecticide neurotoxicity: Recent advances. Archives of Toxicology, 86, 165–181.

Bradberry, S. M., Cage, S. A., Proudfoot, A. T., & Vale, J. A. (2005). Poisoning due to pyrethroids. Toxicological Reviews, 24(2), 93–106.

Casida, J. E., & Durkin, K. A. (2013). Neuroactive insecticides: Targets, selectivity, resistance, and secondary effects. Annual Review of Entomology, 58, 99–117.

Yu, S. J. (2015). The Toxicology and Biochemistry of Insecticides (2nd ed.). CRC Press.

World Health Organization. (2009). Guidelines for Efficacy Testing of Household Insecticide Products: Mosquito Coils, Vaporizer Mats, Liquid Vaporizers, Ambient Emanators and Aerosols. WHO Pesticide Evaluation Scheme.

Roberts, M. S., & Walters, K. A. (Eds.). (2008). Dermal Absorption and Toxicity Assessment (2nd ed.). CRC Press.